30755484|t|Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and gamma-secretase processing of the C99 peptide.
30755484|a|Extracellular deposition of beta-amyloid (Abeta) peptides in the brain is a hallmark of Alzheimer's disease (AD). Upon beta-secretase-mediated cleavage of the beta C-terminal fragment (beta-CTF) from the Abeta precursor protein, the gamma-secretase complex produces the Abeta peptides associated with AD. The familial T43I mutation within the transmembrane domain of the beta-CTF (also referred to as C99) increases the ratio between the Abeta42 and Abeta40 peptides largely due to a decrease in Abeta40 formation. Abeta42 is the principal component of amyloid deposits within the brain parenchyma, and an increase in the Abeta42/Abeta40 ratio is correlated with early-onset AD. Using NMR and FTIR spectroscopy, here we addressed how the T43I substitution influences the structure of C55, the minimal sequence containing the entire extracellular and transmembrane (TM) domains of C99 needed for gamma-secretase processing. 13C NMR chemical shifts indicated that the T43I substitution increases helical structure within the TM domain of C55. These structural changes were associated with a shift of the C55 dimer to the monomer and an increase in the tilt of the TM helix relative to the membrane normal in the T43I mutant compared with that of WT C55. The A21G (Flemish) mutation was previously found to increase secreted Abeta40 levels; here, we combined this mutation in the extracellular domain of C99 with T43I and observed that the T43I/A21G double mutant decreases Abeta40 formation. We discuss how the observed structural changes in the T43I mutant may decrease Abeta40 formation and increase the Abeta42/Abeta40 ratio.
30755484	26	45	Alzheimer's disease	Disease	MESH:D000544
30755484	57	61	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	195	200	Abeta	Gene	351
30755484	241	260	Alzheimer's disease	Disease	MESH:D000544
30755484	262	264	AD	Disease	MESH:D000544
30755484	357	362	Abeta	Gene	351
30755484	423	428	Abeta	Gene	351
30755484	454	456	AD	Disease	MESH:D000544
30755484	471	475	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	591	598	Abeta42	Gene	351
30755484	668	675	Abeta42	Gene	351
30755484	706	722	amyloid deposits	Disease	MESH:D058225
30755484	775	782	Abeta42	Gene	351
30755484	828	830	AD	Disease	MESH:D000544
30755484	891	895	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	1076	1079	13C	Chemical	MESH:C000615229
30755484	1119	1123	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	1363	1367	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	1409	1413	A21G	ProteinMutation	tmVar:p|SUB|A|21|G;HGVS:p.A21G;VariantGroup:0;CorrespondingGene:351;RS#:763852444;CorrespondingSpecies:9606;CA#:9987752
30755484	1563	1567	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	1590	1594	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	1595	1599	A21G	ProteinMutation	tmVar:p|SUB|A|21|G;HGVS:p.A21G;VariantGroup:0;CorrespondingGene:351;RS#:763852444;CorrespondingSpecies:9606;CA#:9987752
30755484	1697	1701	T43I	ProteinMutation	tmVar:p|SUB|T|43|I;HGVS:p.T43I;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
30755484	1757	1764	Abeta42	Gene	351
30755484	Positive_Correlation	MESH:D000544	HGVS:p.T43I;CorrespondingGene:351
30755484	Positive_Correlation	MESH:D000544	351
30755484	Association	MESH:D000544	351

